3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
6
Breast Neoplasms
5
Prostatic Neoplasms
4
Hematologic Neoplasms
4
Colorectal Neoplasms
4
Melanoma
3
Lung Neoplasms
3
Pancreatic Neoplasms
2
Malignant Solid Neoplasm
2
Leukemia, Myeloid, Acute
2
Hematopoietic and Lymphatic System Neoplasm
2
Head and Neck Neoplasms
2
COVID-19
2
Urologic Neoplasms
1
Urologic Diseases
1
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spondylitis, Ankylosing
1
Speech
1
Seroma
1
Rectal Neoplasms
1
Psoriasis
1
Progressive Metastatic Castrate Resistant Prostate Cancer
1
Postoperative Complications
1
Peritoneal Neoplasms
1
Parotid Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Interventions
Cyclophosphamide
4
Vincristine
3
Temozolomide
3
Magnetic Resonance Spectroscopy
3
Ifosfamide
3
Etoposide
3
Doxorubicin
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
liposomal doxorubicin
2
ivosidenib
2
cabozantinib
2
X-Rays
2
Topotecan
2
Specimen Handling
2
Radiation
2
Phantoms, Imaging
2
Nuclear Medicine Department, Hospital
2
Irinotecan
2
Eflornithine
2
Congresses as Topic
2
trifluridine tipiracil drug combination
1
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
larotrectinib
1
irinotecan sucrosofate
1
ganitumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
Standard of Care
×
30 days
×
Clear all
No trials found.